What is Travere Therapeutics, Inc.'s change in AR?

Travere Therapeutics, Inc. (TVTX) reported change in AR of $7.23M in Q1 2026.

How has Travere Therapeutics, Inc.'s change in AR changed year-over-year?

Travere Therapeutics, Inc.'s change in AR increased by 0.3% year-over-year, from $7.2M to $7.23M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Travere Therapeutics, Inc. TVTX Change in AR

Change in AR at other companies

Vertex PharmaceuticalsVRTX

-$39.8M-123%

Ultragenyx PharmaceuticalRARE

-$19M-90.0%

BridgeBio PharmaBBIO

$65.78M-40.5%

Catalyst PharmaceuticalCPRX

$4.36M-24.7%

ANI PharmaceuticalsANIP

-$25.53M-1,333%

Acadia PharmaceuticalsACAD

$13.89M+98.4%

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.2B+72.3%

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s change in AR?: Travere Therapeutics, Inc. (TVTX) reported change in AR of $7.23M in Q1 2026.
How has Travere Therapeutics, Inc.'s change in AR changed year-over-year?: Travere Therapeutics, Inc.'s change in AR increased by 0.3% year-over-year, from $7.2M to $7.23M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.